Publications by authors named "Mathieu Gauthe"

Claim this Profile
D
Deep-learning-based software versus experienced nuclear medicine physician to read [F]-piflufolastat used for PSMA-PET/CT imaging in prostate cancer patients presenting with first biochemical recurrence: A comparative study of detection rate.
Mathieu Gauthé, Sona Balogova

Eur J Nucl Med Mol Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional intra thoracic kidney due to Bochdalek hernia detected in [F]FDG PET/CT performed for lung cancer staging.
Soler Claude, Datry Vincent, Pegard Clothilde, Mathieu Gauthé

Eur J Nucl Med Mol Imaging· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP inhibitors in prostate cancers, is it time for combinations?
Diego Teyssonneau, Charles Dariane, Eric Barret, Jean-Baptiste Beauval, Laurent Brureau

Ther Adv Med Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Letter to the Editor From Jagannath and Mayilvaganan: "FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy and Ultrasonography".
Eugenie Koumakis, Mathieu Gauthé, Alessandro Martinino, Rémy Sindayigaya, Thierry Delbot

J Clin Endocrinol Metab· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: A Systematic Review (French ccAFU).
Amine Saouli, Alain Ruffion, Charles Dariane, Eric Barret, Gaëlle Fiard

Cancers (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]DCFPyL PET/CT versus [F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study.
Daniela-Elena Oprea-Lager, Eric Gontier, Lina García-Cañamaque, Mathieu Gauthé, Pierre Olivier

Eur J Nucl Med Mol Imaging· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?
Michael Baboudjian, Guilhem Roubaud, Gaëlle Fromont, Mathieu Gauthé, Jean-Baptiste Beauval

World J Urol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer.
Rie von Eyben, Manuela Andrea Hoffmann, Cigdem Soydal, Irene Virgolini, Murat Tuncel

Biomedicines· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy and Ultrasonography.
Eugenie Koumakis, Mathieu Gauthé, Alessandro Martinino, Rémy Sindayigaya, Thierry Delbot

J Clin Endocrinol Metab· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III Study of F-PSMA-1007 Versus F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study.
Pierre Olivier, Anne-Laure Giraudet, Andrea Skanjeti, Charles Merlin, Pierre Weinmann

J Nucl Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micro-ultrasound-guided biopsies versus systematic biopsies in the detection of prostate cancer: a systematic review and meta-analysis.
Charles Dariane, Guillaume Ploussard, Eric Barret, Jean-Baptiste Beauval, Laurent Brureau

World J Urol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: von Eyben et al. A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis. 2022, , 5461.
Rie von Eyben, Daniel S Kapp, Manuela Andrea Hoffmann, Cigdem Soydal, Christian Uprimny

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality Goal for Salvage Treatment for Patients with Prostate Cancer at Prostate-specific Antigen Relapse.
Rie von Eyben, Manuela Andrea Hoffmann, Daniel S Kapp, Cigdem Soydal, Christian Uprimny

Eur Urol Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimens.
Alberto Martini, Alae Touzani, Jean-Baptiste Beauval, Alain Ruffion, Jonathan Olivier

World J Urol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis.
Rie von Eyben, Daniel S Kapp, Manuela Andrea Hoffmann, Cigdem Soydal, Christian Uprimny

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative outcomes after radical prostatectomy: does the surgical approach change the impact of hospital volume? A nationwide analysis.
Michael Baboudjian, Bastien Gondran-Tellier, Annabelle Grabia, Eric Barret, Jean-Baptiste Beauval, Mathieu Gauthe

Minerva Urol Nephrol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis.
Michael Baboudjian, Pawel Rajwa, Eric Barret, Jean-Baptiste Beauval, Laurent Brureau

Eur Urol Open Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restaging of Patients with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy Using [Ga]-PSMA-11 Positron Emission Tomography/Computed Tomography: Impact on Disease Management.
Mathieu Gauthé, Paul Sargos, Nicolas Benziane Ouaritini, Eric Barret, Jean-Baptiste Beauval

Eur Urol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers.
Diego Teyssonneau, Antoine Thiery-Vuillemin, Charles Dariane, Eric Barret, Jean-Baptiste Beauval

J Clin Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Annual nationwide analysis of costs and post-operative outcomes after radical prostatectomy according to the surgical approach (open, laparoscopic, and robotic).
Guillaume Ploussard, Annabelle Grabia, Eric Barret, Jean-Baptiste Beauval, Laurent Brureau

World J Urol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Same-day-discharge Robot-assisted Radical Prostatectomy: An Annual Countrywide Analysis.
Guillaume Ploussard, Annabelle Grabia, Eric Barret, Jean-Baptiste Beauval, Laurent Brureau

Eur Urol Open Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 5-Year Contemporary Nationwide Evolution of the Radical Prostatectomy Landscape.
Guillaume Ploussard, Annabelle Grabia, Jean-Baptiste Beauval, Eric Barret, Laurent Brureau

Eur Urol Open Sci· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncologic Impact and Safety of Pre-Operative Radiotherapy in Localized Prostate and Bladder Cancer: A Comprehensive Review from the Cancerology Committee of the Association Française d'Urologie.
Paul Sargos, Stéphane Supiot, Gilles Créhange, Gaëlle Fromont-Hankard, Eric Barret

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of the Development and Use of Akt Inhibitors in Prostate Cancer.
Anis Gasmi, Guilhem Roubaud, Charles Dariane, Eric Barret, Jean-Baptiste Beauval

J Clin Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review.
Mathieu Gauthé, Paul Sargos, Eric Barret, Gaëlle Fromont-Hankard, Jean-Baptiste Beauval

J Clin Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis